Literature DB >> 12427653

Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome.

Doff B McElhinney1, Ian D Krantz, Lynn Bason, David A Piccoli, Karan M Emerick, Nancy B Spinner, Elizabeth Goldmuntz.   

Abstract

BACKGROUND: Cardiovascular anomalies are among the most common features of Alagille syndrome (AGS). Mutations of JAG1 are found in most individuals with AGS. This study was undertaken to determine the spectrum of cardiovascular phenotypes associated with a JAG1 mutation and/or AGS, investigate potential genotype-phenotype correlations, and begin to correlate clinical outcome with genetic pathogenesis. METHODS AND
RESULTS: We reviewed the records of 200 individuals with a JAG1 mutation or AGS. A total of 187 (94%) subjects had evidence of cardiovascular involvement. Cardiovascular anomalies were identified by imaging in 150 subjects (75%), and 37 (19%) had a peripheral pulmonary stenosis murmur with either a normal echocardiogram or no imaging study. Of the 150 subjects with anomalies confirmed by imaging, right-sided anomalies were present in 123 and left-sided anomalies in 22, with both in 12. Seventeen subjects had other anomalies. The most common abnormality was stenosis/hypoplasia of the branch pulmonary arteries (PAs), which was documented by imaging (n=111) or inferred from a peripheral pulmonary stenosis murmur (n=41) in 76% of subjects. Tetralogy of Fallot was present in 23 subjects and was accompanied by pulmonary atresia in 8. Branch PA phenotype differed between individuals with and without a JAG1 mutation. Among subjects with a JAG1 mutation, there was no correlation between the type or location of mutation and the frequency or type of cardiovascular anomaly.
CONCLUSIONS: More than 90% of individuals with a JAG1 mutation or AGS have cardiovascular anomalies, with branch PA stenosis the most common abnormality. Cardiovascular phenotype does not correlate with the type or location of JAG1 mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427653     DOI: 10.1161/01.cir.0000037221.45902.69

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  60 in total

1.  Notch activation of Jagged1 contributes to the assembly of the arterial wall.

Authors:  Lauren J Manderfield; Frances A High; Kurt A Engleka; Feiyan Liu; Li Li; Stacey Rentschler; Jonathan A Epstein
Journal:  Circulation       Date:  2011-12-06       Impact factor: 29.690

Review 2.  Alagille syndrome: pathogenesis, diagnosis and management.

Authors:  Peter D Turnpenny; Sian Ellard
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

Review 3.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

4.  Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.

Authors:  Robert C Bauer; Ayanna O Laney; Rosemarie Smith; Jennifer Gerfen; Jennifer J D Morrissette; Stacy Woyciechowski; Jennifer Garbarini; Kathleen M Loomes; Ian D Krantz; Zsolt Urban; Bruce D Gelb; Elizabeth Goldmuntz; Nancy B Spinner
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

Review 5.  Notch signaling in human development and disease.

Authors:  Andrea L Penton; Laura D Leonard; Nancy B Spinner
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

Review 6.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 7.  The neural crest in cardiac congenital anomalies.

Authors:  Anna Keyte; Mary Redmond Hutson
Journal:  Differentiation       Date:  2012-05-15       Impact factor: 3.880

8.  JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation.

Authors:  Elisa Boscolo; Camille L Stewart; Shoshana Greenberger; June K Wu; Jennifer T Durham; Ira M Herman; John B Mulliken; Jan Kitajewski; Joyce Bischoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-14       Impact factor: 8.311

9.  Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.

Authors:  Jennifer J Hofmann; Anais Briot; Josephine Enciso; Ann C Zovein; Shuxun Ren; Zhen W Zhang; Freddy Radtke; Michael Simons; Yibin Wang; M Luisa Iruela-Arispe
Journal:  Development       Date:  2012-10-24       Impact factor: 6.868

10.  Phenotypic variability in Hey2 -/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome.

Authors:  Andreas Fischer; Barbara Klamt; Nina Schumacher; Christiane Glaeser; Ingo Hansmann; Hartmut Fenge; Manfred Gessler
Journal:  Mamm Genome       Date:  2004-09       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.